Application Sponsors
ANDA 213186 | GRANULES PHARMS | |
Marketing Status
Application Products
001 | TABLET;ORAL | 8MG | 0 | RAMELTEON | RAMELTEON |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2020-08-21 | STANDARD |
LABELING; Labeling | SUPPL | 2 | AP | 2021-08-04 | STANDARD |
LABELING; Labeling | SUPPL | 4 | AP | 2022-03-28 | STANDARD |
Submissions Property Types
ORIG | 1 | Null | 7 |
SUPPL | 2 | Null | 15 |
SUPPL | 4 | Null | 15 |
TE Codes
CDER Filings
GRANULES PHARMS
cder:Array
(
[0] => Array
(
[ApplNo] => 213186
[companyName] => GRANULES PHARMS
[docInserts] => ["",""]
[products] => [{"drugName":"RAMELTEON","activeIngredients":"RAMELTEON","strength":"8MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"08\/21\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2020-08-21
)
)